Kintor Pharmaceutical Limited

We are committed to developing the best therapeutics to improve human health.

Add To Watchlist
General Information
Company Name
Kintor Pharmaceutical Limited
Founded Year
2009
Location (Offices)
China +1
Founders / Decision Makers
Shaoyun Xiang - Chief Technology Officer Guohao Zhou - Chief Medical Officer Chuangxin Guo - Chief Scientific Officer Youzhi Tong - Chief Executive Officer
Number of Employees
29
Industries
Biopharma, Biotechnology, Health Care +2
Funding Stage
Series D
Social Media

Kintor Pharmaceutical Limited - Company Profile

Kintor Pharmaceutical Limited is a China-based startup committed to developing innovative small molecule and biological therapeutics for androgen-receptor and tumor-related diseases, including COVID-19, prostate, breast and liver cancers, alopecia, and acne. The company, founded in 2009, focuses on Biopharma, Biotechnology, Health Care, and Pharmaceutical industries. With its recent $45.00M Series D investment in 28 October 2019 from HighLight Capital, CCB International, FTZ Fund, and Huajin Capital, Kintor Pharmaceutical Limited is well-positioned to continue its growth and impact in the healthcare sector. For more information, visit www.kintor.com.cn. The company's slogan embodies its dedication: "We are committed to developing the best therapeutics to improve human health."

Taxonomy: pharmaceuticals, therapeutics, drug development, small molecule therapeutics, biological therapeutics, androgen-receptor disease, COVID-19, prostate cancer, breast cancer, liver cancer, alopecia treatment, acne treatment, medical innovation

Funding Rounds & Investors of Kintor Pharmaceutical Limited (3)

View All
Funding Stage Amount No. Investors Investors Date
Series D $45.00M 4
HighLight Capital, investor in Kintor Pharmaceutical Limited's Series D round CCB International, investor in Kintor Pharmaceutical Limited's Series D round Acusea/Huiyuan Capital, investor in Kintor Pharmaceutical Limited's Series D round FTZ Fund, investor in Kintor Pharmaceutical Limited's Series D round
28 Oct 2019
Series C $44.00M 6
Green Pine Capital Partners, investor in Kintor Pharmaceutical Limited's Series C round HighLight Capital, investor in Kintor Pharmaceutical Limited's Series C round CCB International, investor in Kintor Pharmaceutical Limited's Series C round Oriza Holdings, investor in Kintor Pharmaceutical Limited's Series C round China Orient Asset Management (International) Holding, investor in Kintor Pharmaceutical Limited's Series C round
Broad Resources 		12 Jan 2018
Venture Round $10.00M - 17 Jul 2015

Latest News of Kintor Pharmaceutical Limited

View All

No recent news or press coverage available for Kintor Pharmaceutical Limited.

Similar Companies to Kintor Pharmaceutical Limited

View All
OS Therapies - Similar company to Kintor Pharmaceutical Limited
OS Therapies Targeting Osteosarcoma, Breast Cancer and other Solid Tumors to prevent HER2-metastasis and destroy solid tumors.
PanTher Therapeutics - Similar company to Kintor Pharmaceutical Limited
PanTher Therapeutics A Quantum Leap Forward in the Fight Against Cancer
Sapphire Biotech - Similar company to Kintor Pharmaceutical Limited
Sapphire Biotech Pioneering advanced therapeutics and diagnostics to enhance global cancer care and ensure early detection and effective treatment monitoring.
HAYA Therapeutics - Similar company to Kintor Pharmaceutical Limited
HAYA Therapeutics Inspired to Transform, The Genome Informs - RNA-Guided Therapeutics to Target Disease Causing Cell-States
AbilityPharma - Similar company to Kintor Pharmaceutical Limited
AbilityPharma Advancing cancer treatment through innovative therapeutics targeting cell membranes.
Circle Decoration Circle Decoration

Want to dive deeper into Kintor Pharmaceutical Limited? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now